HOME > COMMENTARY
COMMENTARY
-
COMMENTARY/Full-Scale M&As Imminent among Dispensing Pharmacy Chains
January 28, 2008
-
No More Need for MRs? -A Hell beyond the 2010 Crisis?-
January 14, 2008
-
COMMENTARY/Year 2007 in Retrospect
December 24, 2007
-
COMMENTARY/Appreciation Mixed with Concern: Proposed NHI Pricing Reform
December 17, 2007
-
COMMENTARY/Fight over Medical Fee/NHI Price Revision Rates Begin
December 3, 2007
-
COMMENTARY:Korosho Must Explain Its "Primary Doctor" System Proposal in Detail
October 1, 2007
-
Gakkai, Specialty Certification and Industry by Mark Colby
September 10, 2007
-
COMENTARY:Korosho Required to Cut \220 Bil. in Social Security Spending
September 3, 2007
-
COMMENTARY/NHI Drug Pricing System Reform: Many Similarities in Proposals from JPMA, PhRMA, EFPIA
August 27, 2007
-
COMMENTARY/Range of Drugs Re-priced due to Expansion of Market May Be Expanded
July 23, 2007
-
COMMENTARY/Market for Osteoporosis Drugs Booms
July 9, 2007
-
COMMENTARY/Pressure Mounting on Long-Listed Original Drugs
July 9, 2007
-
COMMENTARY:Generic Firms Need Stronger Business Platform to Ensure Nationwide Stable Supply
June 25, 2007
-
COMMENTARY/Provisional Deliveries without Agreement on Prices
June 11, 2007
-
COMMENTARY/Show Road Map to the Goal - 30% Share for Generics
June 4, 2007
-
COMMENTARY/Korosho to Consider Introduction of CU System
May 28, 2007
-
Explosion of Shin-Etsu Chemical's Cellulose Production PlantGood Opportunity to Reconsider Raw Material Procurement System
April 30, 2007
-
COMMENTARY/Japan Moves toward Affiliation with PIC/S
April 23, 2007
-
COMMENTARY/India Attracts Increasing Attention of Japanese Pharmas
April 16, 2007
-
COMMENTARY:Growing Market for Biopharmaceuticals
April 2, 2007
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
